Dia-Präsentation von SERVIER EUROPA-Studie (Perindopril) (60 Abbildungen) Übersicht Gesamtpräsentation zum Download (rechte Maustaste und "Ziel speichern unter..." klicken) | ||||||||||||||||||
Abbildung 39: EUROPA-Studie - Endpunkte All components of the primary end point were reduced in favour of perindopril. CV mortality was reduced by 14 %, non fatal MI by 22 % and cardiac arrest by 46 %. Composite of total mortality, non-fatal MI, unstable angina, cardiac arrest was significantly reduced by 14 %. |
Abbildung 39: EUROPA-Studie - Endpunkte
All components of the primary end point were reduced in favour of perindopril. CV mortality was reduced by 14 %, non fatal MI by 22 % and cardiac arrest by 46 %. Composite of total mortality, non-fatal MI, unstable angina, cardiac arrest was significantly reduced by 14 %. |
